Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,960.80
(
0.73%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.97
(
-0.05%
)
Bitcoin
78,235.93
(
2.50%
)
News Focus
News Focus

Replies to post #168 on Cardiol Therapeutics Inc (CRDL)

Replies to #168 on Cardiol Therapeutics Inc (CRDL)
icon url

MahinAgency

11/25/24 10:54 AM

#248 RE: Tiger Money #168

NASDAQ: $CRDL

Advancement: Results support Phase II/III MAVERIC-2 and Phase III MAVERIC-3 trials, expanding accessibility to non-immunosuppressive oral therapy.

Short Squeeze Alerts $CRDL, BIG OPPORTUNITY
Bullish
Bullish